Effient News and Research

RSS
Boston Scientific commences enrollment in its TAXUS Liberte Stent System study

Boston Scientific commences enrollment in its TAXUS Liberte Stent System study

Eli Lilly provides financial guidance for 2010

Eli Lilly provides financial guidance for 2010

VerifyNow System, a rapid platelet function assessment platform, evaluated at AHA's Scientific Sessions

VerifyNow System, a rapid platelet function assessment platform, evaluated at AHA's Scientific Sessions

Updated clinical guidelines on Effient treatment for ACS patients

Updated clinical guidelines on Effient treatment for ACS patients

Comparative Effectiveness Research: One way to beat the competition

Comparative Effectiveness Research: One way to beat the competition

Quest Diagnostics' DNA testing for gene variants help improve outcomes for stent recipients

Quest Diagnostics' DNA testing for gene variants help improve outcomes for stent recipients

HCRI commences patient enrollment in dual antiplatelet therapy study

HCRI commences patient enrollment in dual antiplatelet therapy study

Accumetrics signs a distribution agreement with Grifols for its VerifyNow System in Spain, Portugal and Chile

Accumetrics signs a distribution agreement with Grifols for its VerifyNow System in Spain, Portugal and Chile

FDA approves Effient (prasugrel) for heart attack in angioplasty patients

FDA approves Effient (prasugrel) for heart attack in angioplasty patients

Daiichi Sankyo, Lilly submit NDA for investigational antiplatelet drug, Prasugrelin U.S.

Daiichi Sankyo, Lilly submit NDA for investigational antiplatelet drug, Prasugrelin U.S.